Literature DB >> 11078067

Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy.

C Mattsson1, P Stierna, S Hellström.   

Abstract

HYPOTHESIS: To attempt to inhibit the development of myringosclerosis by intraperitoneal injection of dexamethasone.
BACKGROUND: The authors' earlier report showed that the development of myringosclerosis after myringotomy was associated with an inflammatory reaction. The present study was performed to secure evidence for this hypothesis.
METHODS: Three groups of bilaterally myringotomized rats were treated at 12-hour intervals with intraperitoneal injection of dexamethasone, RU486 (a glucocorticoid receptor antagonist), and saline, respectively. At 6, 12, 24, and 48 hours after the myringotomy, 2 animals were anesthetized on each occasion and examined otomicroscopically. The animals were then killed, and the tympanic membranes were excised and prepared for light microscopic studies.
RESULTS: Dexamethasone treatment retarded and diminished the development of sclerotic lesions markedly. Moreover, no inflammatory signs were seen in the flaccida specimens. When the RU486-treated animals were compared with the animals in the control group, there were no evident differences concerning the development of myringosclerosis or the extent of the inflammatory reaction.
CONCLUSION: These findings confirm the earlier hypothesis that an inflammatory reaction in collagen tissue is involved in the mechanism that causes the development of myringosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078067

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  6 in total

1.  Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis.

Authors:  Necmi Arslan; Davut Tepe; Eren Taştan; Munir Demirci; Muzaffer Caydere; Huseyin Ustun; Haldun Oguz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-25       Impact factor: 2.503

2.  Effect of caffeic acid phenethyl ester on myringosclerosis development in the tympanic membrane of rat.

Authors:  Vefa Kinis; Musa Ozbay; Ulas Alabalik; Aylin Gul; Beyhan Yilmaz; Fazi Emre Ozkurt; Engin Sengul; Ismail Topcu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-27       Impact factor: 2.503

3.  Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids.

Authors:  Carol J MacArthur; J Beth Kempton; Jacqueline DeGagne; Dennis R Trune
Journal:  Otolaryngol Head Neck Surg       Date:  2008-11       Impact factor: 3.497

4.  The impact of topical and systemic enoxaparin sodium use on traumatic tympanic membrane perforation and myringosclerosis.

Authors:  Arif Bilge; Akif Gunes; Muharrem Dagli; F Fulya Koybasioglu; Ali Guvey
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-21       Impact factor: 2.503

5.  The Short-Term Effect of Eugenol on the Prevention of Experimentally Induced Myringosclerosis in a Rat Model.

Authors:  Oğuz Kadir Eğilmez; Mehmet Güven; Sena Genç Elden; Özcan Budak; Hüseyin Çakıroğlu; Halil Elden; Ebru Mihriban Güven
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-07-30

6.  Is there any effect of coenzyme Q10 on prevention of myringosclerosis? Experimental study with rats.

Authors:  Filiz Aydoğan; Emine Aydin; Eren Taştan; Şükran Akgedik; Ahmet Tekeli; Hüseyin Üstün
Journal:  Braz J Otorhinolaryngol       Date:  2013 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.